Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × infigratinib × Clear all

NCT04424966 2025-10-24

Infigratinib in Recurrent High-Grade Glioma Patients

Phase EARLY_PHASE1 Terminated

7 enrolled 18 charts

Glioblastoma, Glioma